CorDynamics Welcomes Dr. William Crumb to Corporate Advisory Team

Chicago, IL (February 2011) - CorDynamics, Inc. is pleased to announce the addition of William Crumb, PhD to its Corporate Advisory Team. Dr. Crumb is a leading expert in cardiac ion channel electrophysiology.

As founder of Zenas Technologies, Dr. Crumb translated his expertise in cardiovascular research into defining the ion channel mechanisms underlying drugs with adverse cardiac effects and characterizing the relationship between hERG block and QT prolongation.

"Dr. Crumb has played a pivotal role in uncovering the mechanisms behind drug-induced ECG changes, specifically focusing on the role of ion channels" said Dr. Michael Gralinski, CorDynamics CEO. "We look forward to working with him in this area."

CorDynamics, Inc. is a comprehensive contract research organization and consulting group focused on examining the cardiovascular effects of emerging drug candidates. The company provides support with discovery and preclinical safety pharmacology studies along with lead optimization screening and consulting for more than 150 biopharmaceutical clients worldwide.

To learn more about CorDynamics, please visit our website at www.cordynamics.com or contact Dr. Gralinski at .

Contact:
Michael R. Gralinski, Ph.D., CorDynamics CEO

William Crumb, Ph.D., Founder of Zenas Technologies